Search Results
Slidesets
Perspectives on the Use of Endogenous Bio-markers to Assess Transporter Mediated Drug-Drug Interations_DDIs - Vikram Arya, PhD, FCP
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Slidesets
Leveraging Reverse Transcriptase 2020 | Kuritzkes
Presented at:
Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020
Slidesets
Laura Waters - Metabolic complications of Antiretroviral Therapy
Presented at:
GCC HIV Clinical Forum 2021
Slidesets
MATRIX - Building Affordable, Acceptable, and Sustainable HIV Prevention Products for LMICs - Shannon Allen.pdf
Presented at:
INTEREST 2023
Slidesets
Improved long acting drug delivery: What are the technologies - Andrew Owen, BSc, MSc, PhD, FSB
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
The Non-adherent Patient A Good or Bad Candidate for CAB+RPV - Jose Castillo-Mancilla, MD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
Nyaradzo Mavis Mgodi, MBChB, MMed - HIV Prevention – Role of Long Acting ARVs
Presented at:
African HIV Clinical Forum 2022
Slidesets
Considerations in Switching to Newer Regimens in Patients Suppressed on Older Drugs - Luis E. Soto-Ramírez
Presented at:
Mexican HIV Clinical Forum 2022